Humanigen Inc Revenue Growth Rates (HGEN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Humanigen Inc  (NASDAQ: HGEN)
 

HGEN's Revenue Growth by Quarter and Year

Humanigen Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HGEN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.22
FY 0.22





HGEN Revenue first quarter 2023 Y/Y Growth Comment
Humanigen Inc reported drop in Revenue in the first quarter 2023 by -78.75% to $ 0.22 millions, from the same quarter in 2022.
The fall in the first quarter 2023 Humanigen Inc's Revenue compares unfavorably to the Company's average Revenue decline of -44.37%.

Looking into first quarter 2023 results within Major Pharmaceutical Preparations industry 243 other companies have achieved higher Revenue growth. While Humanigen Inc' s Revenue meltdown of -78.75% ranks overall at the positon no. 4068 in the first quarter 2023.


HGEN Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - -78.85 % 235.48 % -
3rd Quarter September - -78.85 % - -
2nd Quarter June - 0 % - -
1st Quarter March -78.75 % 112.24 % - -
FY   - -30.19 % 1064.52 % -

Financial Statements
Humanigen Inc's first quarter 2023 Revenue $ 0.22 millions HGEN's Income Statement
Humanigen Inc's first quarter 2022 Revenue $ 1.04 millions Quarterly HGEN's Income Statement


HGEN Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 0 % 0 % -
3rd Quarter September - -78.85 % 0 % -
2nd Quarter June - 0 % 112.24 % -
1st Quarter March 0.45 % 0 % 58.06 % -
FY (Year on Year)   - -30.19 % 1064.52 % -


Back to HGEN Growth rate Comparisons >> Back to HGEN Growth rate Comparisons >>


Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #244
Healthcare Sector #641
Overall #4068

Revenue Y/Y Growth Statistics
High Average Low
232.37 % -44.37 % -100 %
(Dec 31 2021)   (Sep 30 2014)
Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #244
Healthcare Sector #641
Overall #4068
Revenue Y/Y Growth Statistics
High Average Low
232.37 % -44.37 % -100 %
(Dec 31 2021)   (Sep 30 2014)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Humanigen Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4401.45 % 255.8 % -100 %
(Dec 31 2012)  


HGEN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Humanigen Inc disclosed growth in Revenue from the fourth quarter by 0.45% to $ 0.22 millions, from $ 0.22 millions achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Humanigen Inc's Revenue growth quarter on quarter, overall rank is 1897.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #128
Healthcare Sector #331
Overall #1897
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #128
Healthcare Sector #331
Overall #1897
Revenue Q/Q Growth Statistics
High Average Low
4401.45 % 255.8 % -100 %
(Dec 31 2012)  


HGEN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Humanigen Inc disclosed growth in Revenue from the fourth quarter by 0.45% to $ 0.22 millions, from $ 0.22 millions achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Humanigen Inc's Revenue growth quarter on quarter, overall rank is 1897.


Humanigen Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)
Cumulative Revenue 12 Months Ending $ 1.70 $ 2.51 $ 3.33 $ 4.15 $ 4.15
Y / Y Revenue Growth (TTM) -59.01 % -30.07 % 16.03 % - -
Year on Year Revenue Growth Overall Ranking # 1066 # 1366 # 1277 # 0 # 0
Seqeuential Revenue Change (TTM) -32.42 % -24.5 % -19.66 % 0 % 15.3 %
Seq. Revenue Growth (TTM) Overall Ranking # 1106 # 909 # 3195 # 2611 # 940


Cumulative Revenue growth Comment
Humanigen Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -59.01% year on year, at Mar 31 2023 compare to the -30.07% decrease at Dec 31 2022. If the Humanigen Inc's fiscal year would end at Mar 31 2023, annual Revenue would be $2 millions.

In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1066, from total ranking in previous quarter at 1366.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 84
Healthcare Sector # 195
Overall # 1066

Revenue TTM Y/Y Growth Statistics
High Average Low
16.03 %
 -50.08 %
-127.27 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 198
S&P 500 # 1106
Cumulative Revenue growth Comment
Humanigen Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -59.01% year on year, at Mar 31 2023 compare to the -30.07% decrease at Dec 31 2022. If the Humanigen Inc's fiscal year would end at Mar 31 2023, annual Revenue would be $2 millions.

In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1066, from total ranking in previous quarter at 1366.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 84
Healthcare Sector # 195
Overall # 1066

Revenue TTM Y/Y Growth Statistics
High Average Low
16.03 %
-50.08 %
-127.27 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 198
S&P 500 # 1106




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HGEN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2023
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Community Health Systems Inc -0.10%$ -0.096 millions
West Pharmaceutical Services Inc -0.47%$ -0.472 millions
Butterfly Network Inc -0.63%$ -0.629 millions
Qhslab Inc -0.71%$ -0.712 millions
Waters Corporation-0.85%$ -0.854 millions
Dariohealth Corp -0.86%$ -0.856 millions
Fresenius Medical Care Ag-1.06%$ -1.058 millions
Acorda Therapeutics Inc -1.22%$ -1.225 millions
Baxter International Inc -1.56%$ -1.565 millions
Kymera Therapeutics Inc -1.62%$ -1.621 millions
Nature s Sunshine Products inc -1.68%$ -1.683 millions
Organon and Co -1.85%$ -1.851 millions
Scientific Industries Inc -2.08%$ -2.077 millions
Amgen Inc -2.13%$ -2.132 millions
Healthcare Services Group Inc -2.24%$ -2.245 millions
Adaptive Biotechnologies Corporation-2.52%$ -2.519 millions
Bristol myers Squibb Company-2.67%$ -2.670 millions
Caredx Inc -2.71%$ -2.712 millions
Biogen Inc -2.72%$ -2.717 millions
Innovage Holding Corp -2.72%$ -2.718 millions
Cardiff Lexington Corporation-2.73%$ -2.727 millions
Apyx Medical Corp-2.81%$ -2.810 millions
Avanos Medical Inc -2.89%$ -2.888 millions
Align Technology inc -3.09%$ -3.090 millions
Bio rad Laboratories Inc -3.32%$ -3.317 millions
Enhabit Inc -3.35%$ -3.354 millions
National Healthcare Corp-3.38%$ -3.377 millions
Thermogenesis Holdings Inc -3.42%$ -3.417 millions
Mesoblast Limited-3.58%$ -3.580 millions


About Humanigen Inc Revenue Growth Rates (HGEN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Humanigen Inc (CIK 1293310).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001214659-23-007002
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Humanigen Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.